【海王生物:2023年医疗器械营业收入突破120亿元】金融界2月11日消息,海王生物披露投资者关系活动记录表显示,公司2023年医疗器械营业收入已突破120亿元,未来将扩大器械代理纯销业务规模,致力于从市场代理商向拥有外资品牌代理权的企业转型,提升市场竞争力。此外,公司积极与国内知名供应商合作,推动国产医疗器械的市场占有率。

金融界
11 Feb
金融界2月11日消息,海王生物披露投资者关系活动记录表显示,公司2023年医疗器械营业收入已突破120亿元,未来将扩大器械代理纯销业务规模,致力于从市场代理商向拥有外资品牌代理权的企业转型,提升市场竞争力。此外,公司积极与国内知名供应商合作,推动国产医疗器械的市场占有率。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10